Sagimet Biosciences Inc.
Records under this name other than the patents Sagimet Biosciences Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Back to Sagimet Biosciences Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 14/315,133 | Heterocyclic Modulators of Lipid Synthesis Abandoned Abandoned Mar 14, 2016 | Abandoned | Abandoned Mar 14, 2016 | |
| 15/349,960 | Heterocyclic Modulators of Lipid Synthesis Abandoned Abandoned Oct 25, 2018 | Abandoned | Abandoned Oct 25, 2018 | |
| 16/157,672 | Heterocyclic Modulators of Lipid Synthesis Abandoned Abandoned Apr 10, 2020 | Abandoned | Abandoned Apr 10, 2020 | |
| 17/307,985 | Heterocyclic Modulators of Lipid Synthesis Abandoned Abandoned Feb 12, 2024 | Abandoned | Abandoned Feb 12, 2024 | |
| 18/535,291 | Heterocyclic Modulators of Lipid Synthesis Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/709,271 | Methods for Prediction of Treatment Response in Non-Alcoholic Fatty Liver Disease Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/749,069 | Combination Therapies of Fasn Inhibitors with Thyroid Hormone Receptor Agonists Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/490,670 | Industrial Preparation of Heterocyclic Modulator for Lipid Synthesis Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/504,289 | Pharmaceutical Composition Containing Heterocyclic Compound Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/527,665 | Combinations of Fasn Inhibitors and GLP-1 Agonists for Liver Diseases Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |